Prevention of diagnostic and treatment-related sequelae in stage I and II Hodgkin's disease

被引：0
|
作者：
Cox, JD [1 ]
Ha, CS [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
来源：
RADIATION INJURY: ADVANCES IN MANAGEMENT AND PREVENTION | 1999年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 97
页数：13
相关论文
共 50 条
  • [1] Disease- and treatment-related late sequelae in Hodgkin lymphoma
    Behringer, K.
    Oertel, M.
    Rueffer, J. U.
    Borchmann, P.
    ONKOLOGIE, 2022, 28 (10): : 914 - 922
  • [2] Treatment-related sequelae in Hodgkin's lymphoma after mediastinal irradiation
    Shen, Eric Yi-Liang
    Tsan, Din-Li
    Chiang, Yin-yin
    Lin, Shinn-Yn
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (03) : 363 - 370
  • [3] Treatment-related sequelae in Hodgkin’s lymphoma after mediastinal irradiation
    Eric Yi-Liang Shen
    Din-Li Tsan
    Yin-yin Chiang
    Shinn-Yn Lin
    International Journal of Hematology, 2022, 115 : 363 - 370
  • [4] Chemotherapy alone in the treatment of stage I and II Hodgkin's disease.
    Dimopoulos, MA
    Kostourou, A
    Karmiris, T
    Mellou, S
    Pavlidis, N
    Papassavas, P
    Dervenoulas, I
    Papageorgiou, S
    Nikiforakis, E
    Economopoulos, T
    BLOOD, 1998, 92 (10) : 625A - 625A
  • [5] Late relapse after treatment for clinical stage I and II Hodgkin's disease
    Brierley, JD
    Rathmell, AJ
    Gospodarowicz, MK
    Sutcliffe, SB
    Pintillie, M
    CANCER, 1997, 79 (07) : 1422 - 1427
  • [6] Disease and Treatment-Related Sequelae in Patients with Complex Jugulotympanic Paraganglioma
    Harati, Ali
    Schultheiss, Rolf
    Rohde, Stefan
    Deitmer, Thomas
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (03):
  • [7] The impact of radiotherapy dose and other treatment-related and clinical factors on control of stage I and II non-Hodgkin's lymphoma in irradiated sites
    Kamath, SS
    Marcus, RB
    Lynch, JW
    Mendenhall, NP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 322 - 322
  • [8] The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma
    Kamath, SS
    Marcus, RB
    Lynch, JW
    Mendenhall, NP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (03): : 563 - 568
  • [9] Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy
    Tormo, M
    Terol, MJ
    Marugán, I
    Solano, C
    Benet, I
    Garcia-Conde, J
    LEUKEMIA & LYMPHOMA, 1999, 34 (1-2) : 137 - 142
  • [10] Prognostic evaluation of stage I and II subdiaphragmatic Hodgkin's disease.
    Levis, A
    Ricardi, U
    Gavarotti, P
    Allione, B
    Baraldi, A
    Bertini, M
    Depaoli, L
    Gallamini, A
    Pini, M
    Pistone, M
    Cambrin, GR
    Scalabrini, DR
    Salvi, F
    Scassa, E
    Tonso, A
    Vitolo, U
    Botto, B
    Tarella, C
    Gallo, E
    BLOOD, 1999, 94 (10) : 514A - 514A
12345